Cargando…

Characteristics and outcomes of non-Hodgkin’s lymphoma patients with leptomeningeal metastases

BACKGROUND: Leptomeningeal metastasis is an uncommon but devastating complication. The incidence of non-Hodgkin’s lymphoma has been increasing in recent decades, due to the poor central nervous system penetration of drugs and the prolonged overall survival of patients, leptomeningeal metastases has...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Xiangrui, Yu, Jingwei, Fan, Qian, Li, Lanfang, Li, Wei, Song, Zheng, Liu, Xianming, Jiang, Yanyang, Gao, Ming, Zhang, Huilai
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Japan 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097078/
https://www.ncbi.nlm.nih.gov/pubmed/29558001
http://dx.doi.org/10.1007/s10147-018-1268-5
_version_ 1783348232154251264
author Meng, Xiangrui
Yu, Jingwei
Fan, Qian
Li, Lanfang
Li, Wei
Song, Zheng
Liu, Xianming
Jiang, Yanyang
Gao, Ming
Zhang, Huilai
author_facet Meng, Xiangrui
Yu, Jingwei
Fan, Qian
Li, Lanfang
Li, Wei
Song, Zheng
Liu, Xianming
Jiang, Yanyang
Gao, Ming
Zhang, Huilai
author_sort Meng, Xiangrui
collection PubMed
description BACKGROUND: Leptomeningeal metastasis is an uncommon but devastating complication. The incidence of non-Hodgkin’s lymphoma has been increasing in recent decades, due to the poor central nervous system penetration of drugs and the prolonged overall survival of patients, leptomeningeal metastases has gradually increased over time. Patients with leptomeningeal metastases have short survival durations and poor quality of life; there are few studies about non-Hodgkin’s lymphoma with leptomeningeal metastases. We investigated characteristics and outcomes of non-Hodgkin’s lymphoma patients with leptomeningeal metastases. METHODS: This study included 27 non-Hodgkin’s lymphoma patients with leptomeningeal metastases diagnosed at Tianjin Medical University Cancer Institute and Hospital between 2013 and 2016. Statistical analysis was performed to investigate the overall survival of non-Hodgkin’s lymphoma with leptomeningeal metastases. RESULTS: Diffuse large B cell lymphoma was the most common cancer subtype (21/27, 78%), and more than half of the patients showed extranodal involvement (18/27, 67%). Survival analysis has shown extranodal involvement (P = 0.0205), International Prognostic Index (P = 0.0112), performance status (P < 0.0001), parenchymal involvement (P = 0.0330) and received radiotherapy (P = 0.0056) were predictive factors of prognosis for these patients with leptomeningeal metastases. Cox regression analysis has shown patients with concurrent parenchymal involvement and received radiotherapy are correlated with good prognosis. CONCLUSIONS: Given the small number of patients who were included, this study exhibited limitations with respect to analytical power and the random selection of patients. Nevertheless, this investigation revealed characteristics of non-Hodgkin’s lymphoma patients with leptomeningeal metastases and suggested that such patients could benefit from multimodal therapy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10147-018-1268-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6097078
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Japan
record_format MEDLINE/PubMed
spelling pubmed-60970782018-08-24 Characteristics and outcomes of non-Hodgkin’s lymphoma patients with leptomeningeal metastases Meng, Xiangrui Yu, Jingwei Fan, Qian Li, Lanfang Li, Wei Song, Zheng Liu, Xianming Jiang, Yanyang Gao, Ming Zhang, Huilai Int J Clin Oncol Original Article BACKGROUND: Leptomeningeal metastasis is an uncommon but devastating complication. The incidence of non-Hodgkin’s lymphoma has been increasing in recent decades, due to the poor central nervous system penetration of drugs and the prolonged overall survival of patients, leptomeningeal metastases has gradually increased over time. Patients with leptomeningeal metastases have short survival durations and poor quality of life; there are few studies about non-Hodgkin’s lymphoma with leptomeningeal metastases. We investigated characteristics and outcomes of non-Hodgkin’s lymphoma patients with leptomeningeal metastases. METHODS: This study included 27 non-Hodgkin’s lymphoma patients with leptomeningeal metastases diagnosed at Tianjin Medical University Cancer Institute and Hospital between 2013 and 2016. Statistical analysis was performed to investigate the overall survival of non-Hodgkin’s lymphoma with leptomeningeal metastases. RESULTS: Diffuse large B cell lymphoma was the most common cancer subtype (21/27, 78%), and more than half of the patients showed extranodal involvement (18/27, 67%). Survival analysis has shown extranodal involvement (P = 0.0205), International Prognostic Index (P = 0.0112), performance status (P < 0.0001), parenchymal involvement (P = 0.0330) and received radiotherapy (P = 0.0056) were predictive factors of prognosis for these patients with leptomeningeal metastases. Cox regression analysis has shown patients with concurrent parenchymal involvement and received radiotherapy are correlated with good prognosis. CONCLUSIONS: Given the small number of patients who were included, this study exhibited limitations with respect to analytical power and the random selection of patients. Nevertheless, this investigation revealed characteristics of non-Hodgkin’s lymphoma patients with leptomeningeal metastases and suggested that such patients could benefit from multimodal therapy. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10147-018-1268-5) contains supplementary material, which is available to authorized users. Springer Japan 2018-03-20 2018 /pmc/articles/PMC6097078/ /pubmed/29558001 http://dx.doi.org/10.1007/s10147-018-1268-5 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Article
Meng, Xiangrui
Yu, Jingwei
Fan, Qian
Li, Lanfang
Li, Wei
Song, Zheng
Liu, Xianming
Jiang, Yanyang
Gao, Ming
Zhang, Huilai
Characteristics and outcomes of non-Hodgkin’s lymphoma patients with leptomeningeal metastases
title Characteristics and outcomes of non-Hodgkin’s lymphoma patients with leptomeningeal metastases
title_full Characteristics and outcomes of non-Hodgkin’s lymphoma patients with leptomeningeal metastases
title_fullStr Characteristics and outcomes of non-Hodgkin’s lymphoma patients with leptomeningeal metastases
title_full_unstemmed Characteristics and outcomes of non-Hodgkin’s lymphoma patients with leptomeningeal metastases
title_short Characteristics and outcomes of non-Hodgkin’s lymphoma patients with leptomeningeal metastases
title_sort characteristics and outcomes of non-hodgkin’s lymphoma patients with leptomeningeal metastases
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6097078/
https://www.ncbi.nlm.nih.gov/pubmed/29558001
http://dx.doi.org/10.1007/s10147-018-1268-5
work_keys_str_mv AT mengxiangrui characteristicsandoutcomesofnonhodgkinslymphomapatientswithleptomeningealmetastases
AT yujingwei characteristicsandoutcomesofnonhodgkinslymphomapatientswithleptomeningealmetastases
AT fanqian characteristicsandoutcomesofnonhodgkinslymphomapatientswithleptomeningealmetastases
AT lilanfang characteristicsandoutcomesofnonhodgkinslymphomapatientswithleptomeningealmetastases
AT liwei characteristicsandoutcomesofnonhodgkinslymphomapatientswithleptomeningealmetastases
AT songzheng characteristicsandoutcomesofnonhodgkinslymphomapatientswithleptomeningealmetastases
AT liuxianming characteristicsandoutcomesofnonhodgkinslymphomapatientswithleptomeningealmetastases
AT jiangyanyang characteristicsandoutcomesofnonhodgkinslymphomapatientswithleptomeningealmetastases
AT gaoming characteristicsandoutcomesofnonhodgkinslymphomapatientswithleptomeningealmetastases
AT zhanghuilai characteristicsandoutcomesofnonhodgkinslymphomapatientswithleptomeningealmetastases